These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 33730337)

  • 1. A Real-World, Observational Study of the Initiation, Use, and Effectiveness of Basal-Bolus or Premixed Insulin in Japanese People with Type 2 Diabetes.
    Miyoshi H; Baxter M; Kimura T; Hattori M; Morimoto Y; Marinkovich D; Tamiwa M; Hirose T
    Diabetes Ther; 2021 May; 12(5):1341-1357. PubMed ID: 33730337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Real-World Observational Study Evaluating the Probability of Glycemic Control with Basal Insulin or Glucagon-Like Peptide-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes.
    Baxter M; Morimoto Y; Tamiwa M; Hattori M; Peng XV; Lubwama R; Maegawa H
    Diabetes Ther; 2020 Jul; 11(7):1481-1496. PubMed ID: 32445125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Premixed vs basal-bolus insulin regimen in Type 2 diabetes: comparison of clinical outcomes from randomized controlled trials and real-world data.
    Anyanwagu U; Mamza J; Gordon J; Donnelly R; Idris I
    Diabet Med; 2017 Dec; 34(12):1728-1736. PubMed ID: 28945928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basal-bolus Therapy in Patients with Type 2 Diabetes Mellitus in the UK: Patient Characteristics, Treatment Patterns and the Effect of Switching to Premixed Insulin.
    van Brunt K; Curtis B; Ivanyi T; Balogh E; Chalkiadaki C; MacLachlan S; Neasham D; Raluy-Callado M
    Diabetes Ther; 2016 Dec; 7(4):793-807. PubMed ID: 27796906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. iGlarLixi versus premixed insulin initiation in adults with type 2 diabetes advancing from basal insulin therapy: The SoliComplex real-world study.
    Lajara R; Heller C; Pantalone KM; Lew E; Li X; Dex T; Kilpatrick CR
    Diabetes Obes Metab; 2023 May; 25(5):1249-1260. PubMed ID: 36633506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world effectiveness and safety of insulin glargine 300 U/ml in insulin-naïve people with type 2 diabetes in the Latin America region: A subgroup analysis of the ATOS.
    Vargas-Uricoechea H; Burga Nuñez JL; Rosas Guzmán J; Silva-Gomez L; Beltran S; Sañudo-Maury ME
    Diabetes Obes Metab; 2023 Jan; 25(1):238-247. PubMed ID: 36103248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Which Patients Will Benefit from a Switch in Therapy from Premixed Insulin to Insulin Glargine plus Oral Antidiabetic Drugs? Further Analysis of the Lantus Registry Study.
    Bu S; Zhang X; Zhu H; Shuai Y; Xing X; Yang W;
    Diabetes Ther; 2017 Aug; 8(4):887-898. PubMed ID: 28623551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL in Patients with T2D Uncontrolled on NPH or Premixed Insulins as Part of Routine Clinical Practice in Bulgaria: ToUPGRADE Study.
    Kamenov Z; Pehlivanova V; Kuneva T; Kirilov K; Bobeva R; Stoykova J; Mihalevska S
    Diabetes Ther; 2021 Mar; 12(3):913-930. PubMed ID: 33604804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment Intensification in Type 2 Diabetes: A Real-World Study of 2-OAD Regimens, GLP-1 RAs, or Basal Insulin.
    Blonde L; Raccah D; Lew E; Meyers J; Nikonova E; Ajmera M; Davis KL; Bertolini M; Guerci B
    Diabetes Ther; 2018 Jun; 9(3):1169-1184. PubMed ID: 29675797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensification of insulin therapy with basal-bolus or premixed insulin regimens in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.
    Giugliano D; Chiodini P; Maiorino MI; Bellastella G; Esposito K
    Endocrine; 2016 Mar; 51(3):417-28. PubMed ID: 26281001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical study of treatment switching from premixed insulin to basal insulin combined with oral hypoglycemic drugs in patients with type 2 diabetes.
    Zhang Y; Xie YJ; Meng DD; Zhang HH; Chen H; Liu E
    Diabetol Metab Syndr; 2014 Mar; 6(1):37. PubMed ID: 24620742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison.
    Ilag LL; Kerr L; Malone JK; Tan MH
    Clin Ther; 2007; 29 Spec No():1254-70. PubMed ID: 18046926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responses to Basal Insulin Glargine (300 U/mL and 100 U/mL) with or Without Pre-prandial Insulin in Pre-treated Subphenotypes of Type 2 Diabetes: Insights from a Post Hoc Analysis.
    Landgraf W; Owens DR; Frier BM; Bolli GB
    Diabetes Ther; 2024 Aug; 15(8):1769-1784. PubMed ID: 38879736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
    Wenying Y; Benroubi M; Borzi V; Gumprecht J; Kawamori R; Shaban J; Shah S; Shestakova M; Ligthelm R; Valensi P;
    Curr Med Res Opin; 2009 Nov; 25(11):2643-54. PubMed ID: 19751116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycemic Control Following GLP-1 RA or Basal Insulin Initiation in Real-World Practice: A Retrospective, Observational, Longitudinal Cohort Study.
    Peng XV; McCrimmon RJ; Shepherd L; Boss A; Lubwama R; Dex T; Skolnik N; Ji L; Avogaro A; Blonde L
    Diabetes Ther; 2020 Nov; 11(11):2629-2645. PubMed ID: 32902774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of biphasic insulin aspart and biphasic insulin lispro mix in patients with type 2 diabetes: A review of the literature.
    Kumar A
    Indian J Endocrinol Metab; 2016; 20(3):288-99. PubMed ID: 27186543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-world data reveal unmet clinical needs in insulin treatment in Asian people with type 2 diabetes: the Joint Asia Diabetes Evaluation (JADE) Register.
    Kong APS; Lew T; Lau ESH; Lim LL; Kesavadev J; Jia W; Sheu WH; Sobrepena L; Tan ATB; Nguyen TK; Yoon KH; Wang K; Kodiappan K; Treuer T; Chan JCN;
    Diabetes Obes Metab; 2020 Apr; 22(4):669-679. PubMed ID: 31903728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of premixed insulin to achieve glycaemic control in type 2 diabetes: A retrospective UK cohort study.
    Jude EB; Trescoli C; Emral R; Ali A; Lubwama R; Palmer K; Shaunik A; Nanda N; Raskin P; Gomez-Peralta F
    Diabetes Obes Metab; 2021 Apr; 23(4):929-937. PubMed ID: 33319424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IDegLira Improves Glycemic Control in Japanese Patients with Uncontrolled Type 2 Diabetes on Premixed Insulin Therapy.
    Watada H; Ross Agner BF; Doshi A; Bardtrum L; Ranthe MF; Billings LK
    Diabetes Ther; 2020 Jan; 11(1):331-339. PubMed ID: 31760599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IDegLira for the Real-World Treatment of Type 2 Diabetes in Italy: Protocol and Interim Results from the REX Observational Study.
    Fadini GP; Buzzetti R; Fittipaldi MR; D'Incau F; Da Porto A; Girelli A; Simoni L; Lastoria G; Consoli A;
    Diabetes Ther; 2022 Aug; 13(8):1483-1497. PubMed ID: 35717487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.